BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
See today's BioWorld Asia
Home
» Other news to note for Nov. 24, 2020
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Other news to note for Nov. 24, 2020
Nov. 24, 2020
No Comments
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 3Sbio, Adagio, Albany Molecular Research, Almac, Asahi Kasei, Ascletis, Aum Biosciences, Bintai Kinden, Changchun High-Tech Industry, China Biologic Products, Curevac, Eli Lilly, F4, Foresee, Fresenius Kabi, Generex, Generex, Hifibio, Imanis Life Sciences, Immunoprecise Antibodies, Insel Gruppe, Insilico Medicine, Medivir, Merck, Metavant Sciences, Moderna, Mymetics, Newsoara, Ology Bioservices, Pharming, Pharmsynthez, Pierre Fabre, Poxel, Probiogen, Relief, Roivant Sciences, Samsung Biologics, Selecta Biosciences, Sosei, Sotira, Sumitomo Dainippon, Syneos Health, Syngene International, Twist Bioscience, Vifor, Vifor Fresenius Medical Care Renal, Wacker Chemie, Xbiotech, Y-biologics.
BioWorld Asia
Briefs
Other news to note